Pyxis Oncology : to Acquire Apexigen - Form 8-K
Pyxis Oncology to Acquire Apexigen Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate development Commercially and clinically validated APXiMAB... | May 24, 2023
Source: marketscreener.com